-
November 20, 2018 13:45 KST
- Alvotech and Fuji Pharma Enter into Exclusive Partnership for Development and Commercialization of Biosimilars in Japan
- Alvotech and Fuji Pharma (Tokyo Stock Exchange: 4554) today announce that the two companies are entering into ...
-
November 16, 2018 17:25 KST
- SpinalCyte Announces Sustained 12-Month MRI Outcomes After CybroCell™ Injection
- SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus us...
-
November 16, 2018 15:50 KST
- ResMed Completes Acquisition of MatrixCare
- ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-s...
-
November 16, 2018 10:25 KST
- Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies
- Boehringer Ingelheim and Epizyme, Inc. (Nasdaq: EPZM) today announced a new global collaboration focused on th...
-
November 13, 2018 14:30 KST
- Takeda Announces Publication of Circular and Notice of Extraordinary General Meeting of Shareholders in Relation to the Proposed Acquisition of Shire
- Further to the announcement on May 8, 2018, by Takeda Pharmaceutical Company Limited (“Takeda” or the “Company...
-
November 13, 2018 13:10 KST
- International Consensus Statement on Postoperative Anemia Management Recommends Noninvasive Hemoglobin Measurement Including Masimo SpHb®
- Masimo (NASDAQ: MASI) announced today that a new consensus statement on postoperative anemia management was pu...
-
November 06, 2018 17:20 KST
- AlgaEnergy and Yokogawa Sign Strategic Partnership & Equity Agreement to Accelerate Growth of the Microalgae Biotech Sector
- AlgaEnergy, a Spanish biotechnology company specializing in the production and commercial applications of micr...
-
November 06, 2018 13:40 KST
- ResMed to Acquire MatrixCare, Expands Out-of-Hospital SaaS Portfolio into Long-Term Care Settings
- ResMed (NYSE: RMD) (ASX: RMD) today announced it has signed a definitive agreement to acquire privately held M...
-
November 06, 2018 13:30 KST
- OptraSCAN® Unveils High-Speed, High-Throughput, High-Capacity and High-Content “Multi-Modality Digital Slide Scanner”
- OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today unveiled a new Multi-Modality Dig...
-
November 06, 2018 10:35 KST
- Initial results from EMPRISE real-world evidence study shows empagliflozin was associated with reduced risk for hospitalisation for heart failure compared with DPP-4 inhibitors in people with type 2 diabetes with and without cardiovascular disease
- Initial effectiveness results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE)...
-
November 06, 2018 09:00 KST
- Aurigene to Present Multiple Programs at the SITC 2018 in Washington D.C. and EORTC-NCI-AACR 2018 in Dublin
- Aurigene:
SITC - Nov 7-11, Washington D.C.:
(a) CA-170 - Small molecule oral antagonist of PD-L1/VISTA i...
-
November 05, 2018 10:30 KST
- Takeda to Present Data During 60th American Society of Hematology Annual Meeting on Wide Array of Treatment Needs for Blood Cancers
- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that it will present a total of 18 company-s...
-
November 01, 2018 14:20 KST
- Galderma, Nestlé Skin Health’s Medical Solutions Business, Announces Positive Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis
- Galderma, Nestlé Skin Health’s medical solutions business, today announced positive results from a Phase 2b do...
-
November 01, 2018 14:15 KST
- Takeda Reports Second Quarter FY2018 Results
- Takeda Pharmaceutical Company Limited (TOKYO:4502):
Underlying Revenue +4.2%, led by Growth Drivers, with g...
-
October 31, 2018 18:35 KST
- Ferring Announces Retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer
- Ferring Pharmaceuticals today announced that Michel Pettigrew, President of the Executive Board and Chief Oper...
-
October 31, 2018 15:25 KST
- Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer
- Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecular...
-
October 31, 2018 11:35 KST
- Janssen Presents Positive Long-Term Efficacy and Safety of SYMTUZA®▼ (D/C/F/TAF) in Treatment-Naïve Adults with HIV-1
- The Janssen Pharmaceutical Companies of Johnson & Johnson today unveiled 96-week results from the pivotal Phas...
-
October 29, 2018 13:25 KST
- Takeda Comments on Ongoing Phase 1 Review by the European Commission of the Proposed Acquisition of Shire plc
- Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) today issued the following statement with regard ...
-
October 29, 2018 10:50 KST
- Takeda Announces Execution of Senior Short Term Loan Facility Agreement and Subordinated Syndicated Loan Agreement and Second Amendment to Bridge Credit Agreement in Connection with Proposed Acquisition of Shire plc
- Takeda Pharmaceutical Company Limited (TSE:4502) (the “Company or “Takeda”) announces that it has today entere...
-
October 26, 2018 15:40 KST
- Takeda to Highlight Data in Hodgkin Lymphoma During the 11th International Symposium on Hodgkin Lymphoma
- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the company will feature a total of six...
-
October 25, 2018 17:15 KST
- Eminent Scientist James Till Turned Philanthropist; Donates Prize Money to the Cause of Young Researchers
- Stem cell discoverer Prof. James Till, Professor Emeritus, University of Toronto, Canada who was awarded the Edogawa Niche Prize 2018 (www.e...
-
October 25, 2018 13:45 KST
- Morinaga Milk Study Suggests Infant-Type Human-Residential Bifidobacteria May Benefit Infant Health by Improving Digestion of Peptides in Milk and Grains
- Scientists at Morinaga Milk Industry Co., Ltd. (TOKYO:2264) have long theorized that Human-Residential Bifidob...
-
October 23, 2018 14:00 KST
- ResMed Wins German Patent Infringement Case Against Fisher & Paykel
- ResMed (NYSE: RMD) (ASX: RMD), the world’s leading tech-driven medical company and innovator in sleep apnea an...
-
October 22, 2018 18:00 KST
- Outline of New ESMO Guidelines Indicates Inclusion of FOTIVDA®▼ (Tivozanib) for Patients with Advanced Renal Cell Carcinoma
- EUSA Pharma (EUSA) welcomes the news that FOTIVDA®▼ (tivozanib) is expected to be included in the upcoming Eur...
-
October 22, 2018 17:15 KST
- Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Pha...
-
October 22, 2018 16:50 KST
- Edogawa Niche Prize 2018 to Be Awarded to Prof. James Till for Stem Cell Discovery
- The Edogawa Niche Prize 2018, jointly established by Nichi-In Centre for Regenerative Medicine (NCRM) and Edogawa Hospital, Tokyo, Japan wil...
-
October 22, 2018 14:25 KST
- Investigational Subcutaneous Formulation of Vedolizumab Achieves and Maintains Clinical Remission and Mucosal Healing at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis
- Takeda Pharmaceutical Company Limited [TSE:4502] (“Takeda”) today announced results from the phase 3 VISIBLE 1...
-
October 22, 2018 14:10 KST
- Real-world study shows using Giotrif®/Gilotrif® (afatinib) followed by osimertinib provides a median of 27.6 months of chemotherapy-free time in patients with EGFR mutation-positive NSCLC
- Boehringer Ingelheim today announced results from GioTag, a real-world retrospective study which examined the ...
-
October 19, 2018 13:45 KST
- Takeda Receives Clearance from the Japan Fair Trade Commission for the Proposed Acquisition of Shire plc
- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION...
-
October 17, 2018 17:40 KST
- Ferring and Evotec Form Strategic Research Alliance in Reproductive Medicine and Women’s Health
- Ferring Pharmaceuticals and Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today a...
-
October 17, 2018 15:35 KST
- Brightree Launches First Patient App for HME
- Brightree®, the leading provider of cloud-based software to help post-acute care companies improve business pe...
-
October 17, 2018 11:00 KST
- AirFit F30, ResMed’s First Minimal-Contact Full Face CPAP Mask, Now Available in the U.S., Canada
- ResMed (NYSE: RMD, ASX: RMD) today announced the availability of its first minimal-contact full face CPAP mask...
-
October 15, 2018 16:30 KST
- Results from Pradaxa® RE-SPECT ESUS® and RE-SPECT CVT® trials to be presented at the 11th World Stroke Congress
- Boehringer Ingelheim today announced that primary results from two key trials, RE-SPECT ESUS® and RE-SPECT CVT...
-
October 15, 2018 13:45 KST
- Chugai Releases Disease Awareness Anime about Rheumatoid Arthritis in Multiple Languages Emphasizing Importance of Early Detection/Treatment and Care by Specialists
- Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that it released a disease awareness anime about ...
-
October 11, 2018 15:50 KST
- New Analyses from Pivotal Phase 3 Trials of Oral Ozanimod to Be Presented at ECTRIMS 2018
- Celgene Corporation (NASDAQ:CELG) today announced the results of two post hoc analyses of data from the phase ...
-
October 09, 2018 10:35 KST
- Celgene Announces Phase 3 STYLE Study of OTEZLA® (apremilast) in Moderate to Severe Scalp Psoriasis Met Primary Endpoint
- Celgene Corporation (NASDAQ:CELG) today announced results from the phase 3 STYLE study, which showed that OTEZ...
-
October 07, 2018 17:35 KST
- Brightree Launches BrightreeCARE App for Home Health and Hospice Aides
- Brightree®, the leading provider of cloud-based software to help post-acute care companies improve business pe...
-
October 05, 2018 19:40 KST
- Life Biosciences Acquires Lua, Pioneering AI-Driven Healthcare Platform
- Life Biosciences today announced it is acquiring Lua, the communication and technology platform. This bold ste...
-
October 05, 2018 13:50 KST
- Boehringer Ingelheim and Lilly present full results of Trajenta®’s CARMELINA® cardiovascular outcome trial
- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today presented the full results of the long-term c...
-
October 04, 2018 17:25 KST
- PharmAbcine Announces FDA Accepts IND Application of TTAC-0001 for the Treatment of Recurrent Glioblastoma
- PharmAbcine, Inc, a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer ...
-
October 02, 2018 20:00 KST
- Seattle Genetics and Takeda Announce Positive Results from Phase 3 ECHELON-2 Clinical Trial Evaluating ADCETRIS® (Brentuximab Vedotin) in Frontline CD30-Expressing Peripheral T-Cell Lymphoma
- Seattle Genetics, Inc. (Nasdaq:SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) announced today that...
-
October 02, 2018 14:25 KST
- New Study Evaluates the Ability of Masimo ORi™ to Help Clinicians Reduce Hyperoxemia in Mechanically Ventilated ICU Patients
- Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the 2018 Congress of the French...
-
October 01, 2018 00:35 KST
- Takeda Establishes Record Date for the Extraordinary General Meeting of Shareholders
- Further to the announcement of the recommended acquisition of Shire plc (“Shire”) on May 8, 2018 (“the Acquisi...
-
September 28, 2018 15:20 KST
- Takeda to Present Positive Data from ALUNBRIG® (brigatinib) ALTA-1L Trial Showing a Reduction in Risk of Disease Progression or Death of More Than 50 Percent Versus Crizotinib in First-Line Advanced ALK+ NSCLC
- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced results from the Phase 3 ALTA-1L (ALK in Lun...
-
September 27, 2018 14:00 KST
- Global survey reveals that physicians need more information to assess the impact of treatment sequencing on patient survival in EGFR mutation-positive NSCLC
- Results from a new global survey revealed that more than one-third (36%) of the 310 physicians surveyed do not...
-
September 26, 2018 18:25 KST
- WIPO and IFPMA Launch New Online Patent-Search Resource to Help Health Agencies Procure Medicines
- WIPO and the research-based pharmaceutical industry today launched a new online tool designed to help procurem...
-
September 25, 2018 19:25 KST
- Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib
- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) C...
-
September 19, 2018 16:00 KST
- 175 Million Europeans Have Sleep Apnoea, Highlighting Scale of Global Health Crisis
- Roughly 175 million Europeans have obstructive sleep apnoea, according to a late-breaking abstract presented b...
-
September 19, 2018 09:00 KST
- Aspect Biosystems Announces Liver Tissue Collaboration with JSR
- Aspect Biosystems, a privately held biotechnology company focused on commercializing cutting-edge bioprinting ...
-
September 18, 2018 15:55 KST
- THE NUVISAN GROUP Continues Its Growth by Adding Parts of the GALDERMA R&D Capabilities from NESTLÉ SKIN HEALTH
- On August 31st the NUVISAN GROUP, one of Europe´s leading CRO´s focused on early stage drug development for th...
-
September 17, 2018 22:05 KST
- MEDTEX: Foresee the Next Wave of Healthcare Revolution
- Taiwan, with high quality medical service and world’s top IT industry, has becoming one of the leaders in glob...
-
September 17, 2018 18:15 KST
- Large European real-world study reports effects of Spiolto® Respimat® for people living with COPD in daily clinical practice[1]
- For media excluding the United States of America, Canada and the United Kingdom
Boehringer Ingelheim announ...
-
September 17, 2018 10:15 KST
- Clinical trial data for nintedanib in patients with advanced IPF published
- Results from the INSTAGE® trial have been presented at the 2018 European Respiratory Society (ERS) conference ...
-
September 17, 2018 10:05 KST
- New study results provide evidence that Ofev® (nintedanib) slows progression of IPF beyond four years with consistent safety
- Results from INPULSIS®-ON, published today in Lancet Respiratory Medicine, provide insights into the long-term...
-
September 14, 2018 16:00 KST
- ResMed Introduces Its First Minimal-contact Full Face CPAP Mask, AirFit F30
- ResMed (NYSE: RMD) (ASX: RMD) today introduced its first minimal-contact full face CPAP mask, AirFit F30, the ...
-
September 14, 2018 15:00 KST
- Acelity Enters Agreement to Transition Systagenix Manufacturing Facility to Scapa Healthcare
- Today, Acelity announced an agreement to sell its advanced wound dressings manufacturing facility located in G...
-
September 13, 2018 18:25 KST
- Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
- Boehringer Ingelheim today announced that it has acquired all shares of ViraTherapeutics, a biopharmaceutical ...
-
September 13, 2018 17:30 KST
- OptraSCAN® Receives CE Mark Approval for In-Vitro Diagnostics Use
- OptraSCAN®, the leading end-to-end digital pathology solution provider, today announced that their whole-slide...
-
September 13, 2018 10:10 KST
- OTEZLA® (Apremilast) Showed Meaningful Improvements in Clinical and Quality-of-Life Measures of Psoriasis Beyond Those Captured by Assessing Skin Alone
- Celgene Corporation (NASDAQ:CELG) today announced the results of two post hoc sub-analyses of clinical trials ...
-
September 10, 2018 22:05 KST
- dClinic(DHC) Phase 1 - Over 50% SOLD in first 10 days
- “Current Blockchains are not dedicated Healthcare blockchains. They are not purpose built to handle fractal cl...
-
September 07, 2018 09:45 KST
- Swiss Advanced Vision Launches Harmonis - The First Customizable EDOF IOL for Cataract Surgery
- Swiss Advanced Vision (SAV-IOL) has announced the launch of Harmonis, a customizable intraocular lens (IOL) wi...
-
September 06, 2018 14:40 KST
- JAMA Publishes Greatly Anticipated Phase III Study Using 22nd Century’s SPECTRUM® Very Low Nicotine Content Cigarettes
- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reductio...
-
September 06, 2018 10:50 KST
- New Study Compares Two Methods of Guiding Goal-Directed Fluid Therapy, Noninvasive Masimo PVi® and Invasive Esophageal Doppler
- Masimo (NASDAQ: MASI) announced today the findings of a study recently published in BMC Anesthesiology in whic...
-
September 05, 2018 10:15 KST
- Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases
- Boehringer Ingelheim and Tsinghua University in Beijing announce a collaboration aiming to research and develo...
-
September 03, 2018 13:45 KST
- GNT Pharma's Ropesalazine Effective in Treating Dog Dementia
- GNT Pharma said Ropesalazine, a drug candidate for Alzheimer’s disease (AD), has shown an outstanding benefici...
-
September 03, 2018 11:40 KST
- ResMed Files Patent Infringement Action against Fisher & Paykel
- ResMed (NYSE: RMD) (ASX: RMD), the world’s leading tech-driven medical device company and innovator in sleep a...
-
August 31, 2018 11:55 KST
- Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs
- Nebula Genomics announced today that it has raised $4.3M million in seed financing with participation from 10 ...
-
August 31, 2018 10:50 KST
- Ferring and Celmatix Launch Ambitious Genomics Collaboration to Advance Care in Reproductive Medicine and Women’s Health
- Ferring Pharmaceuticals and Celmatix today announced an ambitious genomics collaboration aimed at uncovering n...
-
August 28, 2018 14:00 KST
- ResMed’s Astral Life Support Ventilator Now Has AutoEPAP in U.S.
- ResMed (NYSE: RMD) (ASX: RMD), a global leader in cloud-connected respiratory care devices, today announced ke...
-
August 28, 2018 11:25 KST
- New Study Evaluates the Ability of Masimo ORi™ to Reflect Oxygenation During Moderate Hyperoxia
- Masimo (NASDAQ: MASI) announced today the findings of a study recently published in Anesthesia & Analgesia in ...
-
August 27, 2018 16:10 KST
- GN Hearing Introduces New Interton Ready™ Hearing Aid with Excellent Connectivity and Personalized Sound at a Compelling Price
- GN Hearing, one of the world’s leading hearing aid manufacturers and the pioneer of 2.4 GHz wireless connectiv...
-
August 23, 2018 11:30 KST
- 22nd Century Receives Order for 3.6 Million SPECTRUM® U.S. Government Research Cigarettes
- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reductio...
-
August 20, 2018 17:05 KST
- Boehringer Ingelheim: New sub-analyses to be presented at ESC Congress 2018 further support positive safety profile of Pradaxa® (dabigatran etexilate)
- Boehringer Ingelheim today announced that it will present nine sub-analyses from the RE-DUAL PCI™ trial and GL...
-
August 17, 2018 10:45 KST
- GN Hearing and Google Announce Partnership to Bring Direct Mobile Streaming from Android Devices to Hearing Aids
- GN Hearing and Google have today announced a new technology partnership that will make GN Hearing the first ma...
-
August 15, 2018 22:05 KST
- 2018 Healthcare+ Expo Taiwan: Where Tech Meets Medicine
- From November 29th to December 2nd 2018, global-leading biomedical and technology institutes will gather in Ta...
